Both in Pharmaceuticals
Skye Bioscience vs Xenetic Biosciences
Over the past year SKYE returned −90.0% and XBIO returned −29.5%; their daily moves had a correlation of 0.07.
SKYE −90.0% XBIO −29.5%Growth of $1, one year, split-adjusted
| Metric | SKYE | XBIO |
|---|---|---|
| Price | $1.14 | $2.01 |
| Market cap | $5.0M | $4.7M |
| Today | −6.56% | −3.37% |
| 1 month | −29.6% | −5.2% |
| 6 months | −83.3% | −36.6% |
| Year to date | −81.0% | −7.4% |
| 1 year | −90.5% | −35.6% |
| Revenue growth (YoY) | — | +12.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −140.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $9.9M | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 616.5% | 158.5% |
| Short % of float | 0.6% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).